147 related articles for article (PubMed ID: 31562388)
1. En masse discovery of anti-cancer human monoclonal antibodies by de novo assembly of immunoglobulin sequences from transcriptomes and genome sequences of cancer tissues.
Zhang P; Chou HY; Young L; Zheng P; Liu Y
Cell Mol Immunol; 2019 Dec; 16(12):943-945. PubMed ID: 31562388
[No Abstract] [Full Text] [Related]
2. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
3. A blueprint for tumor-infiltrating B cells across human cancers.
Ma J; Wu Y; Ma L; Yang X; Zhang T; Song G; Li T; Gao K; Shen X; Lin J; Chen Y; Liu X; Fu Y; Gu X; Chen Z; Jiang S; Rao D; Pan J; Zhang S; Zhou J; Huang C; Shi S; Fan J; Guo G; Zhang X; Gao Q
Science; 2024 May; 384(6695):eadj4857. PubMed ID: 38696569
[TBL] [Abstract][Full Text] [Related]
4. B cells, plasma cells and antibody repertoires in the tumour microenvironment.
Sharonov GV; Serebrovskaya EO; Yuzhakova DV; Britanova OV; Chudakov DM
Nat Rev Immunol; 2020 May; 20(5):294-307. PubMed ID: 31988391
[TBL] [Abstract][Full Text] [Related]
5. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
Front Immunol; 2021; 12():592031. PubMed ID: 34335558
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.
Wang W; Zou W; Liu JR
Gynecol Oncol; 2018 Oct; 151(1):1-3. PubMed ID: 30243508
[No Abstract] [Full Text] [Related]
7. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antibodies for discovery, therapy, and vaccine acceleration.
Andreano E; Seubert A; Rappuoli R
Curr Opin Immunol; 2019 Aug; 59():130-134. PubMed ID: 31450054
[TBL] [Abstract][Full Text] [Related]
9. [Strategies around PD-L1 testing in France].
Penault-Llorca F
Ann Pathol; 2017 Feb; 37(1):3-4. PubMed ID: 28108043
[No Abstract] [Full Text] [Related]
10. 8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015--May 20-22, Vancouver, Canada.
Boudreau JE; Wouters MC; Krawczyk CM
Cancer Immunol Immunother; 2016 Feb; 65(2):235-41. PubMed ID: 26759005
[No Abstract] [Full Text] [Related]
11. Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer?
Ledermann JA
Gynecol Oncol; 2019 May; 153(2):213-214. PubMed ID: 31027611
[No Abstract] [Full Text] [Related]
12. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy.
Yu WD; Sun G; Li J; Xu J; Wang X
Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563
[TBL] [Abstract][Full Text] [Related]
13. Significance and Role of Pattern Recognition Receptors in Malignancy.
Żeromski J; Kaczmarek M; Boruczkowski M; Kierepa A; Kowala-Piaskowska A; Mozer-Lisewska I
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):133-141. PubMed ID: 30976817
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers.
Inthagard J; Edwards J; Roseweir AK
Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159
[TBL] [Abstract][Full Text] [Related]
15. Checkpoint Inhibitors: Conquering Cancer with a Little (T)-Help from Our Microbial Friends.
Asmar N; Ibrahim T; Rey JF
Dig Dis Sci; 2018 Sep; 63(9):2177-2179. PubMed ID: 29982987
[No Abstract] [Full Text] [Related]
16. Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis.
Steele KE; Tan TH; Korn R; Dacosta K; Brown C; Kuziora M; Zimmermann J; Laffin B; Widmaier M; Rognoni L; Cardenes R; Schneider K; Boutrin A; Martin P; Zha J; Wiestler T
J Immunother Cancer; 2018 Mar; 6(1):20. PubMed ID: 29510739
[TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines: limited success but the research should remain viable.
Baxevanis CN; Perez SA
Expert Rev Vaccines; 2016 Jun; 15(6):677-80. PubMed ID: 26796430
[No Abstract] [Full Text] [Related]
18. Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing.
Zhang L; Zhang Z
Cancer Immunol Res; 2019 Jul; 7(7):1040-1046. PubMed ID: 31262773
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer.
Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN
Front Immunol; 2021; 12():731329. PubMed ID: 35069521
[TBL] [Abstract][Full Text] [Related]
20. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies.
Zirakzadeh AA; Marits P; Sherif A; Winqvist O
J Immunol; 2013 Jun; 190(11):5847-55. PubMed ID: 23630345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]